Zacks Investment Research
30 Jul 2026, 01:36 UTC · 6w ago
Verdict
Headline leans bullish. We score BHC −0.20 across three claims.
Score contradicts the headline.
Leans bullish
From its wording — no explicit rating
−0.20slightly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Bausch Health (BHC) reported quarterly earnings of $1.26 per share, exceeding the Zacks Consensus Estimate of $0.96 per share by 31.25%.
More positive than 77% of claims this week
Bausch Health reported quarterly revenues of $2.85 billion, surpassing consensus estimates by 7.62%.
Continue reading
5 related stories
More negative than 69% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 65% of claims this week
The stock currently holds a Zacks Rank #5 (Strong Sell) due to an unfavorable trend in earnings estimate revisions.
More negative than 72% of claims this week
Which stocks this story touches
More negative than 69% of ticker scores this week
Despite beating earnings and revenue estimates, the company has a Zacks Rank #5 (Strong Sell) and has underperformed the market significantly this year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
5h ago
+21.2%
Price is moving against the score
$5.67 vs $4.68 close before publication (Jul 29) · not market-adjusted
BHC chart →
